Related by context. Frequent words. (Click for all words.) 73 forodesine 73 phase IIa clinical 72 phase IIb clinical 71 Phase Ib clinical 71 multicenter Phase 70 relapsed refractory multiple myeloma 70 Phase IIb trials 69 registrational 69 placebo controlled Phase 69 Panzem R 69 Phase 2a clinical 69 Phase 2a trial 69 relapsed multiple myeloma 69 Azedra 68 deforolimus 68 liposomal formulation 68 Pivotal Phase III 68 Amrubicin 68 pertuzumab 68 Cloretazine R VNP#M 68 enzastaurin 68 phase IIa 68 Phase 1b clinical 68 multi kinase inhibitor 68 CR# vcMMAE 68 Phase IIa trial 67 INCB# [001] 67 R sorafenib tablets 67 romidepsin 67 confirmatory Phase III 67 tanespimycin 67 phase IIb 67 BAY #-# 67 registrational trial 67 StemEx 67 Phase 2b study 67 Phase 1b trial 66 relapsing multiple sclerosis 66 dose escalation trial 66 ganetespib 66 GLPG# 66 Traficet EN 66 multiple myeloma MM 66 Phase IIIb 66 anticancer compound 66 Phase IIB 66 phase 2a 66 Pivotal Trial 66 placebo controlled clinical 66 diabetic neuropathic pain 66 randomized Phase III 66 Phase IIa clinical 66 KRN# 66 IMC A# 66 refractory Hodgkin lymphoma 65 Phase Ib 65 Phase 2b clinical 65 PEG SN# 65 IND submission 65 RGB # 65 Phase Ia 65 subcutaneous formulation 65 elotuzumab 65 Tesetaxel 65 Mipomersen 64 atacicept 64 Phase III pivotal 64 IIa trial 64 glufosfamide 64 CoFactor 64 MKC# 64 Diabetic Macular Edema 64 Phase IIb clinical 64 Phase 2b trial 64 Fibrillex TM 64 Icatibant 64 Phase 2b clinical trials 64 Completes Enrollment 64 Pervasis 64 OncoVEX GM CSF 64 Kiadis Pharma 64 drug eluting coronary stent 64 Phase 1b 64 Vilazodone 64 TELCYTA 64 HER2 positive metastatic breast 64 Pirfenidone 64 lymphoma CTCL 64 metastatic hormone refractory 64 Carfilzomib 64 EndoTAG TM -1 64 Pivotal Phase 64 Cetrorelix 64 cutaneous T cell 64 HGS ETR1 64 Allovectin 7 R 63 Phase IIb trial 63 L Annamycin 63 Sym# 63 multicenter clinical 63 ATL# [001]